Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African–American patients: a community-based retrospective cohort study-Reference-Cited by-同舟云学术

Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African–American patients: a community-based retrospective cohort study

Published:2018-10 Issue:10 Volume:30 Page:1200-1207
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Gayam Vijay,Tiongson Benjamin,Khalid Mazin,Mandal Amrendra K.,Mukhtar Osama,Gill Arshpal,Garlapati Pavani,Shrestha Binav,Khalid Mowyad,Chakraborty Sandipan,Guss Debra,Sherigar Jagannath,Mansour Mohammed,Mohanty Smruti

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. The impact of hepatitis C burden: an evidence-based approach;Younossi;Aliment Pharmacol Ther,2014

2. Estimating progression to cirrhosis in chronic hepatitis C virus infection;Freeman;Hepatology,2001

3. Effect of hepatitis C virus and its treatment on survival;Butt;Hepatology,2009

4. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies;Morgan;Ann Intern Med,2013

5. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus–Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi;Journal of Clinical Oncology;2022-12-10

2. Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings;Future Virology;2022-07

3. Real-world evidence of sofosbuvir/velpatasvir as an effective and simple hepatitis C virus treatment and elimination tool in homeless populations;Future Virology;2022-02

4. The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals;PLOS ONE;2021-12-02

5. The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals;2021-09-10